00000nam 2200000zi 4500 9.931903 CaOODSP 20240103081217 m o d f cr |n||||||||| 240102e202209 oncd o f000 0 eng d CaOODSP eng rda CaOODSP n-cn--- H14-480/2022E-PDF Evaluation of Health Canada’s Blood Research and Development Program 2017-18 to 2021-22 / prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. Evaluation of the Blood Research and Development Program - September 2022 [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, September 2022. 1 online resource (iii, 12 pages) : graphs text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Évaluation du Programme de recherche et de développement sur le sang de Santé Canada de 2017-2018 à 2021-2022. "This report presents the findings of the evaluation of the Blood Research and Development Program (BR&D) for the period from 2017-18 to 2021-22. The purpose of the evaluation was to examine the impact of activities of the Canadian Blood Services funded by Health Canada under the BR&D Program in supporting the safety of Canada’s blood supply system"--Executive summary, page ii. Blood Collection and preservation Canada Safety measures Evaluation. Blood Research Canada Finance. Canada. Health Canada, issuing body. Public Health Agency of Canada, issuing body. Évaluation du Programme de recherche et de développement sur le sang de Santé Canada de 2017-2018 à 2021-2022 / (CaOODSP)9.931948 PDF 620 KB https://publications.gc.ca/collections/collection_2024/sc-hc/H14-480-2022-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/evaluation/blood-research-development-program-2017-18-2021-22.html